Trial Profile
Phase I/II trial of PYN17 in patients with chronic hepatitis C
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 16 Feb 2016
Price :
$35
*
At a glance
- Drugs PYN 17 (Primary)
- Indications Hepatitis C
- Focus Adverse reactions
- Sponsors Phynova
- 16 Feb 2016 New trial record